
51 - 200 employees
Founded 2004
🧬 Biotechnology
💊 Pharmaceuticals
💰 $75M Post IPO equity on 2024-02
Biotechnology • Pharmaceuticals
Liquidia is a biopharmaceutical company focused on developing inhaled therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company leverages its proprietary PRINT® particle engineering technology to create proprietary formulations and delivery methods aimed at improving efficacy, tolerability, and convenience of inhaled medicines; its pipeline includes inhaled treprostinil (commercial product) and clinical-stage candidates such as L606. Liquidia emphasizes patient support, clinical development, and advancing therapies for improved respiratory outcomes.
🕒 November 3
🇺🇸 United States – Remote
💵 Estimated: $177,000 - $233,000 / year
⏰ Full Time
🟠 Senior
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 10%
Where this job comes from
Posted on Liquidia Corporation's careers page ↗, not through a job board
First seen by Remote Rocketship November 3
Still open on Liquidia Corporation's site. Checked 2 hours ago.

51 - 200 employees
Founded 2004
🧬 Biotechnology
💊 Pharmaceuticals
💰 $75M Post IPO equity on 2024-02
Biotechnology • Pharmaceuticals
Liquidia is a biopharmaceutical company focused on developing inhaled therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company leverages its proprietary PRINT® particle engineering technology to create proprietary formulations and delivery methods aimed at improving efficacy, tolerability, and convenience of inhaled medicines; its pipeline includes inhaled treprostinil (commercial product) and clinical-stage candidates such as L606. Liquidia emphasizes patient support, clinical development, and advancing therapies for improved respiratory outcomes.
• Develop and implement cross-functional development plans at strategic and tactical levels • Understand functional interfaces and drive cross-functional alignment to achieve corporate milestones • Escalate risks effectively to senior management and develop and implement mitigation strategies • Plan with the end in mind to assess commercial viability throughout the product life cycle • Facilitate regular team and cross-functional meetings • Develop dashboards and provide status updates to senior management • Assist with budgeting and track study and operational budgets to ensure efficient resource allocation across projects • Monitor evolving regulatory requirements and quality trends across modalities • Ensure readiness and proactive compliance planning • Co-lead the planning, execution, and delivery of clinical trials for the L606 and Yutrepia programs • Collaborate with internal and external stakeholders across Operations, Product Development, Clinical Operations, Regulatory, Medical Affairs, Commercial, and vendors • Provide oversight of vendor relationships, development timelines, and budgetary timelines
• Bachelor’s degree and a minimum of 8 years of relevant experience with a focus on matrix management • Advanced degree (MS, PhD, MBA) preferred in a relevant biopharmaceutical discipline • Experience with program management from IND to NDA/BLA and global launch, including understanding of global registration processes • Experience with Phase 4 studies preferred • Experience in the biotech/pharmaceutical industry • Demonstrated understanding of cross-functional interdependencies across R&D, commercial, technical development, and regulatory • Experience managing integrated timelines, critical paths, resource constraints, and dependencies across concurrent development programs • Ability to lead, motivate, and influence without authority • Ability to leverage and develop diverse perspectives and ideas from matrix teams • Excellent communication, negotiation, problem-solving, and decision-making abilities • Ability to develop forecasts, assess resource variances, and communicate risks • Ability to establish decision logs, ownership, escalation pathways, and follow-through across matrix teams • Ability to identify critical program risks and develop mitigation plans • Experience supporting combination device programs, inhaled technologies, and/or small molecules strongly preferred • Proven experience managing complexity in global programs across multiple modalities • Proficiency with project management and reporting tools, such as Smartsheet • PMP or equivalent project/program management training preferred
• Competitive compensation package • Medical insurance • Dental insurance • Vision insurance • Short-term disability (STD) • Long-term disability (LTD) • 401(k) Savings Retirement Plan • Employee Stock Purchase Plan (ESPP) • Equal opportunity employment • Reasonable accommodation for qualified individuals with disabilities
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 November 3
Medical writing director leading clinical and regulatory documents for Dyne Therapeutics’ neuromuscular disease programs. Guiding FDA and global health authority submissions across cross-functional teams.
🇺🇸 United States – Remote
💵 $190k - $235k / year
🔥 Funding within the last year
💰 $300M Post-IPO Equity on 2026-07
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🕒 November 3
Medical Director overseeing ophthalmology clinical studies and medical monitoring for Syneos Health’s integrated biopharmaceutical programs. Supporting safety, protocol development, clinical data review, and investigator training.
🕒 November 3
Medical communications director advancing Syndax Pharmaceuticals' cancer therapies. Leading scientific engagement, congress strategy, sponsored education, budgets, vendors, and compliant medical content.
🕒 November 3
Medical Director reviewing inpatient records and claims for medical necessity at Humana, a U.S. healthcare and insurance company. Making utilization management determinations and partnering with providers remotely.
🇺🇸 United States – Remote
💵 $223.8k - $313.1k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
👨⚕️ Medical Director
🦅 H1B Visa Sponsor
🕒 November 3
Clinical drug safety leader supporting Centessa’s orexin medicines for narcolepsy and sleep-wake disorders. Driving signal management, aggregate reports, ICSR oversight, and pharmacovigilance compliance.
🇺🇸 United States – Remote
💵 $117k - $189.2k / year
💰 $6.5M Post-IPO Debt - Eli Lilly on 2024-02
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director